Aripiprazole in the treatment of challenging behaviour in adults with autism spectrum disorder

Psychopharmacology

Volumn 223, Issue 3, 2012, Pages 357-360

  Jordan, Iain ^a,b   Robertson, Dene ^a,b   Catani, Marco ^a,b   Craig, Michael ^a,b   Murphy, Declan ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b BETHLEM ROYAL HOSPITAL   (United Kingdom)

Author keywords

Antipsychotics; Aripiprazole; Autism; Autism spectrum disorders; Behavioural disorders; Neuropsychiatry

Indexed keywords

ARIPIPRAZOLE; CLOMIPRAMINE; CLOZAPINE; LITHIUM; LORAZEPAM; OLANZAPINE; RISPERIDONE; VALPROIC ACID;

ADULT; AGGRESSION; AGITATION; AKATHISIA; AROUSAL; ARTICLE; ASPERGER SYNDROME; AUTISM; CATATONIA; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; COHORT ANALYSIS; COMPULSION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; EXERCISE; FEMALE; HALLUCINATION; HUMAN; MALE; MENTAL HEALTH; MOOD; MOOD DISORDER; MOTOR DYSFUNCTION; NEUTROPENIA; OBSESSIVE COMPULSIVE DISORDER; PARANOIA; PRIORITY JOURNAL; SCHIZOPHRENIA; SOCIAL INTERACTION; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ANTIPSYCHOTIC AGENTS; BEHAVIOR; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; FEMALE; HUMANS; MALE; PIPERAZINES; QUINOLONES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84866738145     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-012-2723-z     Document Type: Article

References (21)

1. Brambilla P, Hardan A et al (2003) Brain anatomy and development in autism: Review of structural MRI studies. Brain Res Bull 61 (6):557-569
2. Burris KD, Molski TF et al (2002) Aripiprazole, a novel antipsychotic, is a high-Affinity partial agonist at human dopamine D2 receptors. J Pharmacol Exp Ther 302(1):381-389
3. Courchesne E, Campbell K et al (2010) Brain growth across the life span in autism: Age-specific changes in anatomical pathology. Brain Res 1380:138-145
4. Erickson CA, Stigler KA et al (2011) A prospective open-label study of aripiprazole in fragile X syndrome. Psychopharmacology 216 (1):85-90
5. Fombonne E (2009) Epidemiology of pervasive developmental disorders. Pediatr Res 65(6):591-598
6. Grunder G, Fellows C et al (2008) Brain and plasma pharmacokinetics of aripiprazole in patients with schizophrenia: An [18F]fallypride PET study. Am J Psychiatry 165(8):988- 995
7. Guy W (1976) ECDEU Assessment Manual for Psychopharmacology- Revised. Department of Health Services, Rockville, MD, U.S. Department of Health and Human Services, pp 218-222
8. Jarbrink K, Knapp M (2001) The economic impact of autism in Britain. Autism 5(1):7-22
9. Langen M, Durston S et al (2007) Caudate nucleus is enlarged in highfunctioning medication-naive subjects with autism. Biol Psychiatry 62(3):262-266
10. Lord C, Rutter M et al (1994) Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 24(5):659-685
11. Malone RP, Waheed A (2009) The role of antipsychotics in the management of behavioural symptoms in children and adolescents with autism. Drugs 69(5):535-548
12. Marcus RN, Owen R et al (2009) A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry 48(11):1110-1119
13. Masi G, Cosenza A et al (2009) Aripiprazole monotherapy in children and young adolescents with pervasive developmental disorders: A retrospective study. CNS Drugs 23(6):511-521
14. Matson JL, Sipes M et al (2011) Issues in the management of challenging behaviours of adults with autism spectrum disorder. CNS Drugs 25(7):597-606
15. McAlonan GM, Cheung Vet al (2005) Mapping the brain in autism. A voxel-based MRI study of volumetric differences and intercorrelations in autism. Brain 128(Pt 2):268-276
16. McDougle CJ, Stigler KA et al (2008) Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders. J Clin Psychiatry 69(Suppl 4):15-20
17. Owen R, Sikich L et al (2009) Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics 124(6):1533-1540
18. Schumann CM, Barnes CC et al (2009) Amygdala enlargement in toddlers with autism related to severity of social and communication impairments. Biol Psychiatry 66(10):942-949
19. Staller JA (2003) Aripiprazole in an adult with Asperger disorder. Ann Pharmacother 37(11):1628-1631
20. Stigler KA, Posey DJ et al (2004) Aripiprazole for maladaptive behavior in pervasive developmental disorders. J Child Adolesc Psychopharmacol 14(3):455-463
21. Stigler KA, Diener JT et al (2009) Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: A 14-week, prospective, open-label study. J Child Adolesc Psychopharmacol 19(3):265-274